Showing results (41-50 of 55) with videos related to
Sort By:
Pageof 6
Nature Microbiology|July 25, 2020
LY6E impairs coronavirus fusion and confers immune control of viral diseaseStephanie Pfaender, Katrina B Mar, Eleftherios Michailidis, et al.Immunity|April 21, 2022
Analysis of memory B cells identifies conserved neutralizing epitopes on the N-terminal domain of variant SARS-Cov-2 spike proteinsZijun Wang, Frauke Muecksch, Alice Cho, et al.Cell Reports|May 31, 2024
Human antibodies in Mexico and Brazil neutralizing tick-borne flavivirusesTomás Cervantes Rincón, Tania Kapoor, Jennifer R Keeffe, et al.Cell|October 27, 2015
Engineering a therapeutic lectin by uncoupling mitogenicity from antiviral activityMichael D Swanson, Daniel M Boudreaux, Loïc Salmon, et al.Proceedings of the National Academy of Sciences of the United States of America|September 8, 2011
Inhibition of influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomersSamuel W Gerritz, Christopher Cianci, Sean Kim, et al.Nature|December 11, 2024
Small-molecule inhibition of SARS-CoV-2 NSP14 RNA cap methyltransferaseCindy Meyer, Aitor Garzia, Michael W Miller, et al.Nature|June 20, 2020
Convergent antibody responses to SARS-CoV-2 in convalescent individualsDavide F Robbiani, Christian Gaebler, Frauke Muecksch, et al.Biorxiv : the Preprint Server for Biology|June 9, 2020
Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent IndividualsDavide F Robbiani, Christian Gaebler, Frauke Muecksch, et al.The Journal of Experimental Medicine|February 5, 2021
Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccinePaul Bastard, Eleftherios Michailidis, Hans-Heinrich Hoffmann, et al.The Journal of Experimental Medicine|July 5, 2019
Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccinesNicholas Hernandez, Giorgia Bucciol, Leen Moens, et al.Pageof 6